Immunological measurement of transforming growth factor-beta I (TGF- β1) in blood; assay development and comparison

Clinical Chemistry

Volumn 43, Issue 10, 1997, Pages 1965-1974

  Kropf, Jürgen ^a   Schurek, Josef O ^a   Wollner, Antje ^a   Gressner, Axel M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BINDING PROTEIN; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; HUMAN; IMMUNOASSAY; PH; PROTEIN FAMILY; PROTEIN POLYMORPHISM; THROMBOCYTE;

EID: 0030776705     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.10.1965     Document Type: Article

References (29)

1. Lawrence DA. Transforming growth factor-beta: an overview. Kidney Int 1995;47:S19-23.
2. Roberts AB, Sporn MB. The transforming growth factor-beta. In: Sporn MB, Roberts AB., eds. Peptide growth factors and their receptors. Handbook of experimental pharmacology. Heidelberg: Springer Verlag, 1990:419-72.
3. Paralkar VM, Vukicevic S, Reddi AH. Transforming growth factor-beta type 1 binds to collagen IV of basement membrane matrix: implications for development. Devel Biol 1991;143:303-8.
4. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990;346:281-4.
5. Webb DJ, Crookston KP, Figler NL, LaMarre J, Gonias SL. Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat. Biochem J 1995;312:579-86.
6. Webb DJ, Crookston KP, Hall SW, Gonias SL. Binding of transforming growth factor-betal to immobilized human alpha2-macroglobulin. Arch Biochem Biophys 1992;292:487-92.
7. Kong FM, Anscher MS, Murase T, Abbott BD, Iglehart JD, Jirtle RL. Elevated plasma transforming growth factor-beta1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg 1995;222:155-62.
8. Ito N, Kawata S, Tamura S, Shirai Y, Kiso S, Tsushima H, Matsuzawa Y. Positive correlation of plasma transforming growth factor-beta1 levels with tumor vascularity in hepatocellular carcinoma. Cancer Lett 1995;89:45-8.
9. Muller F, Aukrust P, Nilssen DE, Froland SS. Reduced serum level of transforming growth factor-beta in patients with IgA deficiency. Clin Immunol Immunopathol 1995;76:203-8.
10. Jiang X, Kanai H, Hiromura K, Sawamura M, Yano S. Increased intraplatelet and urinary transforming growth factor-beta in patients with multiple myeloma. Acta Haematol 1995;94:1-6.
11. Zauli G, Gugliotta L, Catani L, Vianelli N, Borgatti P, Belmonte MM, Tura S. Increased serum levels of transforming growth factor beta1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis. Br J Haematol 1993;84:381-6.
12. Taketazu F, Miyagawa K, Ichijo H, Oshimi K, Mizoguchi H, Hirai H, et al. Decreased level of transforming growth factor-beta in blood lymphocytes of patients with aplastic anemia. Growth Factors 1992;6:85-90.
13. Snowden N, Coupes B, Herrick A, Illingworth K, Jayson MIV, Brenchley PEC. Plasma TGF beta in systemic sclerosis: a cross-sectional study. Ann Rheum Dis 1994;53:763-7.
14. Randall LA, Wadhwa M, Thorpe R, Mire-Sluis AR. A novel, sensitive bioassay for transforming growth factor-beta. J Immunol Methods 1993;164:61-7.
15. Szymkowiak CH, Mons I, Gross WL, Kekow J. Determination of transforming growth factor-beta2 in human blood samples by ELISA. J Immunol Methods 1995;184:263-71.
16. Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, Kemp PR. Active and acid-activated TGF-beta in human sera, platelets, and plasma. Clin Chim Acta 1995;235:11-31.
17. Phillips AO, Steadman R, Donovan KD, Williams JD. A new antibody capture enzyme linked immunoassay specific for transforming growth factor-beta1. Int J Biochem Cell Biol 1995;27: 207-13.
18. Danielpour D. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor-beta1. J Immunol Methods 1993;158:17-25.
19. Meager A. Assays for transforming growth factor-beta [Review]. J Immunol Methods 1991;141:1-14.
20. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RSH, Pai LH, et al. Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1995;1:129-36.
21. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. J Clin Chem Clin Biochem 1983;21:709-20.
22. Perrin DD, Sayce IG. Computer calculation of equilibrium concentrations in mixtures of metal ions and complexing species. Talanta 1967;14:833-42.
23. Ginzburg G. Calculation of all equilibrium concentrations in a system of competing complexation. Talanta 1976;23:149-52.
24. Reisenbichler H, Jirtle RL. BSA treatment of plasticware reduces TGF-beta binding. Biotechniques 1994;17:675-6.
25. Greiling H, Gressner AM, eds. Lehrbuch der Klinischen Chemie und Pathobiochemie. Stuttgart: Schattauer Verlag, 1995:233-4.
26. Miller DM, Ogawa Y, Iwata KK, ten Dijke P, Purchio AF, Soloff MS, Gentry LE. Characterization of the binding of transforming growth factor-beta1, -beta2, and -beta3 to recombinant beta1-latency-associated peptide. Mol Endocrinol 1992;6:694-702.
27. Butler JE, Cantareo LA, Swanson P, McGivern PL. The amplified enzyme-linked immunosorbent assay (a-ELISA) and its applications. In: Maggio ET, ed. Enzyme-immunoassay. Boca Raton, FL: CRC Press, 1981:197-212.
28. Miyazono K, Dijke ten P, Ichijo H, Helding CH. Receptors for transforming growth factor-beta [Review]. Adv Immunol 1994;55: 181-220.
29. Assoian RK, Sporn MB. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 1986;102:1217-23.